BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34824268)

  • 21. A global DNA methylation and gene expression analysis of early human B-cell development reveals a demethylation signature and transcription factor network.
    Lee ST; Xiao Y; Muench MO; Xiao J; Fomin ME; Wiencke JK; Zheng S; Dou X; de Smith A; Chokkalingam A; Buffler P; Ma X; Wiemels JL
    Nucleic Acids Res; 2012 Dec; 40(22):11339-51. PubMed ID: 23074194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C/EBPa-mediated activation of microRNAs 34a and 223 inhibits Lef1 expression to achieve efficient reprogramming into macrophages.
    Rodriguez-Ubreva J; Ciudad L; van Oevelen C; Parra M; Graf T; Ballestar E
    Mol Cell Biol; 2014 Mar; 34(6):1145-57. PubMed ID: 24421386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulation of kinase signaling and lymphoid development in EBF1-PDGFRB ALL leukemogenesis.
    Welsh SJ; Churchman ML; Togni M; Mullighan CG; Hagman J
    Leukemia; 2018 Jan; 32(1):38-48. PubMed ID: 28555080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional repression of Gata3 is essential for early B cell commitment.
    Banerjee A; Northrup D; Boukarabila H; Jacobsen SE; Allman D
    Immunity; 2013 May; 38(5):930-42. PubMed ID: 23684985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MEF2C and EBF1 Co-regulate B Cell-Specific Transcription.
    Kong NR; Davis M; Chai L; Winoto A; Tjian R
    PLoS Genet; 2016 Feb; 12(2):e1005845. PubMed ID: 26900922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Runx1 is essential at two stages of early murine B-cell development.
    Niebuhr B; Kriebitzsch N; Fischer M; Behrens K; Günther T; Alawi M; Bergholz U; Müller U; Roscher S; Ziegler M; Buchholz F; Grundhoff A; Stocking C
    Blood; 2013 Jul; 122(3):413-23. PubMed ID: 23704093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ebf1 and c-Myb repress rag transcription downstream of Stat5 during early B cell development.
    Timblin GA; Schlissel MS
    J Immunol; 2013 Nov; 191(9):4676-87. PubMed ID: 24068669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin.
    Wang Y; Zolotarev N; Yang CY; Rambold A; Mittler G; Grosschedl R
    Immunity; 2020 Dec; 53(6):1151-1167.e6. PubMed ID: 33159853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
    Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
    Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Proteomic Investigation of Ebf1 Heterozygosity in Pro-B Lymphocytes Utilizing Data Independent Acquisition.
    Musa YR; Boller S; Puchalska M; Grosschedl R; Mittler G
    J Proteome Res; 2018 Jan; 17(1):76-85. PubMed ID: 29181981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early B-cell factor 1 (EBF1) is critical for transcriptional control of SLAMF1 gene in human B cells.
    Schwartz AM; Putlyaeva LV; Covich M; Klepikova AV; Akulich KA; Vorontsov IE; Korneev KV; Dmitriev SE; Polanovsky OL; Sidorenko SP; Kulakovskiy IV; Kuprash DV
    Biochim Biophys Acta; 2016 Oct; 1859(10):1259-68. PubMed ID: 27424222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-step transcriptional priming that drives the commitment of multipotent progenitors toward B cells.
    Miyai T; Takano J; Endo TA; Kawakami E; Agata Y; Motomura Y; Kubo M; Kashima Y; Suzuki Y; Kawamoto H; Ikawa T
    Genes Dev; 2018 Jan; 32(2):112-126. PubMed ID: 29440259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
    Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
    Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia.
    Chen D; Zheng J; Gerasimcik N; Lagerstedt K; Sjögren H; Abrahamsson J; Fogelstrand L; Mårtensson IL
    PLoS One; 2016; 11(9):e0162638. PubMed ID: 27611867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The novel adaptor protein Swiprosin-1 enhances BCR signals and contributes to BCR-induced apoptosis.
    Avramidou A; Kroczek C; Lang C; Schuh W; Jäck HM; Mielenz D
    Cell Death Differ; 2007 Nov; 14(11):1936-47. PubMed ID: 17673920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Noncoding RNA Expression during Human B-Cell Development.
    Petri A; Dybkær K; Bøgsted M; Thrue CA; Hagedorn PH; Schmitz A; Bødker JS; Johnsen HE; Kauppinen S
    PLoS One; 2015; 10(9):e0138236. PubMed ID: 26394393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KLF2--a negative regulator of pre-B cell clonal expansion and B cell activation.
    Winkelmann R; Sandrock L; Kirberg J; Jäck HM; Schuh W
    PLoS One; 2014; 9(5):e97953. PubMed ID: 24874925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
    Steeghs EMP; Boer JM; Hoogkamer AQ; Boeree A; de Haas V; de Groot-Kruseman HA; Horstmann MA; Escherich G; Pieters R; den Boer ML
    Sci Rep; 2019 Mar; 9(1):4634. PubMed ID: 30874617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebf1 or Pax5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia.
    Heltemes-Harris LM; Willette MJ; Ramsey LB; Qiu YH; Neeley ES; Zhang N; Thomas DA; Koeuth T; Baechler EC; Kornblau SM; Farrar MA
    J Exp Med; 2011 Jun; 208(6):1135-49. PubMed ID: 21606506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.